Quiz Ref ID Randomized clinical trials (RCTs) have demonstrated the benefit of endovascular-reperfusion therapy over medical therapy among patients with large vessel occlusion in acute ischemic stroke (AIS).
1-6 Several studies suggest a strong time dependency of greater benefit with earlier treatment.
7-10 Existing data regarding the relation of onset-to-treatment time and outcome, however, is limited in precision and representativeness. The pooled analysis of RCTs was of modest size (536 patients undergoing endovascular-reperfusion therapy in 5 trials),
8 and RCT findings may not be directly generalizable to routine clinical practice. Observational studies similarly have been underpowered to delineate time effects with high precision.
1,7,10,11 To address the need for analysis of a large, practice-based data set, the US nationwide Get With the Guidelines-Stroke (GWTG-Stroke) registry was analyzed to determine the association of time to treatment with outcomes from endovascular-reperfusion therapy.